Bank of New York Mellon’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-217,625
Closed -$8.36M 4447
2023
Q2
$8.36M Buy
217,625
+22,273
+11% +$856K ﹤0.01% 2031
2023
Q1
$4.52M Sell
195,352
-25,707
-12% -$595K ﹤0.01% 2358
2022
Q4
$5.79M Buy
221,059
+10,567
+5% +$277K ﹤0.01% 2255
2022
Q3
$4.14M Buy
210,492
+17,710
+9% +$348K ﹤0.01% 2389
2022
Q2
$3.37M Buy
192,782
+39,472
+26% +$690K ﹤0.01% 2535
2022
Q1
$2.51M Buy
153,310
+11,759
+8% +$192K ﹤0.01% 2815
2021
Q4
$2.31M Buy
141,551
+11,952
+9% +$195K ﹤0.01% 2902
2021
Q3
$1.65M Buy
129,599
+12,280
+10% +$157K ﹤0.01% 3101
2021
Q2
$1.66M Buy
117,319
+47,239
+67% +$667K ﹤0.01% 3120
2021
Q1
$1.09M Sell
70,080
-3,348
-5% -$52K ﹤0.01% 3280
2020
Q4
$1.16M Buy
73,428
+12,710
+21% +$201K ﹤0.01% 3171
2020
Q3
$738K Buy
60,718
+848
+1% +$10.3K ﹤0.01% 3295
2020
Q2
$691K Buy
59,870
+494
+0.8% +$5.7K ﹤0.01% 3302
2020
Q1
$814K Buy
59,376
+8,203
+16% +$112K ﹤0.01% 3109
2019
Q4
$302K Buy
51,173
+6,099
+14% +$36K ﹤0.01% 3796
2019
Q3
$239K Sell
45,074
-1,600
-3% -$8.48K ﹤0.01% 3849
2019
Q2
$360K Sell
46,674
-6,902
-13% -$53.2K ﹤0.01% 3738
2019
Q1
$1.07M Buy
53,576
+951
+2% +$18.9K ﹤0.01% 3128
2018
Q4
$695K Buy
52,625
+7,868
+18% +$104K ﹤0.01% 3305
2018
Q3
$1.65M Buy
44,757
+708
+2% +$26K ﹤0.01% 2963
2018
Q2
$1.54M Buy
44,049
+7,277
+20% +$255K ﹤0.01% 3001
2018
Q1
$1.71M Buy
36,772
+2,798
+8% +$130K ﹤0.01% 2896
2017
Q4
$1.27M Sell
33,974
-1,154
-3% -$43.3K ﹤0.01% 3095
2017
Q3
$1.87M Buy
35,128
+6,768
+24% +$360K ﹤0.01% 2879
2017
Q2
$1.62M Sell
28,360
-1,273
-4% -$72.5K ﹤0.01% 2969
2017
Q1
$1.59M Buy
29,633
+1,094
+4% +$58.8K ﹤0.01% 2986
2016
Q4
$1.63M Buy
28,539
+4,223
+17% +$241K ﹤0.01% 2975
2016
Q3
$1.51M Buy
24,316
+3,944
+19% +$245K ﹤0.01% 2943
2016
Q2
$1.15M Buy
20,372
+9,097
+81% +$514K ﹤0.01% 3046
2016
Q1
$723K Buy
11,275
+2,588
+30% +$166K ﹤0.01% 3249
2015
Q4
$1.22M Buy
8,687
+4,143
+91% +$583K ﹤0.01% 3031
2015
Q3
$440K Sell
4,544
-1,282
-22% -$124K ﹤0.01% 3600
2015
Q2
$883K Buy
+5,826
New +$883K ﹤0.01% 3407